Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jennifer Champoux currently holds 35,649 shares of Monte Rosa Therapeutics, Inc. (GLUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer Champoux has been a net seller of GLUE stock. They have purchased $0 and sold $43.5K worth of shares.
Jennifer Champoux's most recent insider trade was on May 27, 2026, when they sold 2,175 shares at $0.00 per share.
Jennifer Champoux serves as Executive at Monte Rosa Therapeutics, Inc. (GLUE). They have executed 4 insider transactions totaling $43.5K over their tenure at the company.
Jennifer Champoux holds the position of Executive at Monte Rosa Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Jennifer Champoux has shown a selling trading pattern, with $0 in total purchases and $43.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jennifer Champoux was on May 27, 2026, when they sold $43.5K worth of GLUE shares. This transaction involved 2,175 shares at $20.00 per share.
Jennifer Champoux currently owns 35,649 shares of Monte Rosa Therapeutics, Inc. (GLUE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jennifer Champoux's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jennifer Champoux has 4 Form 4 filings on record as an insider at Monte Rosa Therapeutics, Inc..
Set alerts for Jennifer Champoux and 40,000+ other insiders.